Trial · NCT07899723
TimelyCare - A Proactive Primary Care Model: Delivering the Right Care at the Right Time for Individuals at Risk of High Care Consumption
NCT07899723, Not applicable, Enrolling by invitation, Linnaeus University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. TimelyCare - A Proactive Primary Care Model: Delivering the Right Care at the Right Time for Individuals at Risk of High Care Consumption. Trials, record NCT07899723. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07899723
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- TimelyCare - A Proactive Primary Care Model: Delivering the Right Care at the Right Time for Individuals at Risk of High Care Consumption
- NCT number
- NCT07899723
- Status
- Enrolling by invitation
- Phases
- Not applicable
- Enrollment
- 1,200 participants, estimated
- Lead sponsor
- Linnaeus University
- Conditions
- Multimorbidity, Integrated Care, Primary Care Patients With Chronic Conditions, Coordination, Administrative
- Interventions
- Timely Care,
- First posted
- 2026-10-27
- Last updated
- 2026-10-27
Source ClinicalTrials.gov
Registered outcomes8
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Unplanned Hospital Admission Rate | Baseline (pre-intervention retrospective trajectory, 2014-2025) through 18-month post-implementation follow-up (September 2025-March 2027) | Rate of unplanned emergency hospital admissions per 1,000 person-years. Evaluated using quarterly regional healthcare register data via Interrupted Time Series (ITS) with segmented regression analysis to assess post-implementation changes compared to the baseline trajectory |
| Secondary | Emergency Department (ED) Visit Rate | Quarterly from baseline up to 18 months post-implementation | Rate of emergency department visits and emergency admissions per 1,000 person-years |
| Secondary | 30-Day Unplanned Hospital Readmissions | Quarterly over the 18-month follow-up period | Proportion of patients experiencing an unplanned hospital readmission within 30 days of discharge |
| Secondary | Average Length of Hospital Stay | Quarterly over the 18-month follow-up period | Average duration of unplanned hospital stay measured in days |
| Secondary | Patient-Experienced Continuity of Care Score | Baseline, 6, 12, and 18 months post-enrolment | Evaluated using the validated Patient-Experienced Continuity of Care Questionnaire (PECQ; short version), measuring four dimensions: informational, relational, management, and knowledge continuity |
| Secondary | Health-Related Quality of Life (HRQoL) and QALYs | Baseline, 6, 12, and 18 months post-enrolment | Evaluated using the EQ-5D-5L index score and Visual Analogue Scale (VAS), converted to Quality-Adjusted Life Years (QALYs) for health economic utility analysis |
| Secondary | Incremental Cost-Effectiveness Ratio (ICER) | Baseline to 18-month post-implementation horizon | Incremental cost per avoided unplanned hospital admission, integrating direct healthcare costs (DRG/Cost per Patient database, Prescribed Drug Register) and municipal home care expenditures |
| Secondary | Implementation Capacity Score (IPAT) | Baseline, 6, 12, and 18 months | Measured among healthcare staff using the Implementation Process Assessment Tool (IPAT) to evaluate organizational readiness, implementation capacity, and sustainment over time |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07899723
GET https://conductscience.org/api/trials/v1/NCT07899723/registered